Beta-1 selective adrenergic receptor antagonist
This page covers all Beta-1 selective adrenergic receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor.
Targets
Marketed (1)
- Nebivolol (NEB) · Mylan Bertek Pharmaceuticals · Cardiovascular
Nebivolol is a selective beta-1 adrenergic receptor antagonist that also has vasodilatory properties through nitric oxide release.
Patent intelligence
- beta 1 selective adrenergic receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates